Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

Share Price is delayed by 15 minutes
Get Live Data
1,173.00    -27.00 (-2.25%)
Bid:
1,172.00
Ask:
1,174.00
Spread: 2.00 (0.171%)
Market Cap: £815.73m
CVSG Live PriceLast checked at - London Stock Exchange

Intraday CVS Group Share Chart

Trading Update

23 Jul 2013 08:09

RNS Number : 9168J
CVS Group plc
23 July 2013
 

 

23 July 2013

 

CVS Group plc (the "Group")

 

Trading Update

 

The Board is pleased to announce that the results for the year ended 30 June 2013 will be in line with market expectations and will be released on Tuesday 24 September 2013.

 

Total like-for-like Group turnover for the year showed growth of 3.4%. This growth was achieved despite sales being moderately impacted by snow during January (0.2% impact) and there being one fewer trading days in the second half of 2013 compared to 2012 (0.3% impact).

 

Good organic growth has been achieved in the core veterinary practices throughout the year. The period has seen growth of over 70% in the membership of loyalty schemes which now exceed 111,900 pets compared to 65,500 at this time last year. At current run rates loyalty schemes are contributing over 9% of the total revenue from practices.

 

It is pleasing to report that there has been significant growth in the e-commerce operations. Animed Direct is currently generating some £6.7 million of annualised revenue, compared with £3.5 million at 30 June 2012 and continues to show significant growth opportunities. In addition, five on-line practice shops were opened during the year.

 

Internally funded acquisition activity has continued to play an important part in the Group's strategy. In addition to the three practices and the pet crematorium acquired in the first half of the year, four practices, Cranmore (two sites in Chester), Archway (Petersfield), Alver (three sites in and around Gosport) and Filham Park (Ivy Bridge, Devon) were acquired during the second half. These four acquisitions extend the Group's practice division's operations and the sites are an excellent geographic fit with the Group's existing surgeries. All of the acquisitions have been successfully integrated into the Group. Subsequent to the year end on 15 July 2013, Crescent (Melton Mowbray) was acquired. Based on the last financial year prior to acquisition the aggregate turnover derived from these five additional practices amounted to £8.3 million.

 

As well as small animal services, the Filham Park and Crescent practices both include some equine activities, extending our offering in this area. The Cranmore acquisition includes a referrals centre and on 1 July 2013 Professor John Innes joined us as a Referrals Director to run and expand our referrals business. John has been a leading figure in the academic and animal orthopaedic worlds for many years; most recently he has been closely involved in developing clinical services at the University of Liverpool. Not only will John bring world class experience in orthopaedics to the Group, but he will also bring experience and expertise in the development of referral services.

 

In total the Group now operates 248 veterinary practices across the UK, an on-line dispensary and 11 on-line practice shops, 5 diagnostic laboratories and 2 pet crematoria. CVS continues to be the UK's largest operator in a highly fragmented market.

 

For further enquiries please contact:

 

CVS Group plc: 01379 644 288

Simon Innes - Chief Executive

Nick Perrin - Finance Director

 

N+1 Singer 020 7496 3000

Aubrey Powell

Graeme Summers

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGMGZNNFKGFZG
Date   Source Headline
28th Nov 20088:36 amRNSHolding(s) in Company
27th Nov 20088:32 amRNSHolding(s) in Company
24th Nov 20081:51 pmRNSHolding(s) in Company
20th Nov 20082:10 pmRNSLTIP Award
14th Nov 20081:03 pmRNSAnnual Report and Accounts
14th Nov 20087:00 amRNSAcquisition
29th Oct 200810:44 amRNSHolding(s) in Company
27th Oct 20084:45 pmRNSSecond Price Monitoring Extn
27th Oct 20084:38 pmRNSPrice Monitoring Extension
7th Oct 20087:00 amRNSAcquisition
19th Sep 200812:27 pmRNSHolding(s) in Company
16th Sep 20087:00 amRNSPreliminary Results
1st Sep 20087:00 amRNSShareSave Scheme
28th Aug 200810:48 amRNSHolding(s) in Company
5th Aug 20089:25 amRNSHolding(s) in Company
17th Jul 20087:00 amRNSHolding(s) in Company
8th Jul 20087:00 amRNSPre-Close Trading Update
7th Jul 20082:26 pmRNSHolding(s) in Company
12th May 20084:40 pmRNSNotifiable Shareholding
25th Apr 20086:04 pmRNSHolding(s) in Company
2nd Apr 20085:28 pmRNSDirector/PDMR Shareholding
26th Mar 20082:22 pmRNSHolding(s) in Company
25th Mar 20089:50 amRNSHolding(s) in Company
18th Mar 20087:02 amRNSAcquisition
18th Mar 20087:01 amRNSInterim Results
26th Feb 20087:01 amRNSAcquisition
18th Feb 20084:00 pmRNSNotice of Results
21st Jan 20084:33 pmRNSHolding(s) in Company
14th Jan 20081:55 pmRNSHolding(s) in Company
10th Jan 20087:00 amRNSAcquisition
13th Dec 20077:01 amRNSAcquisitions/Trading Update
12th Dec 20073:27 pmRNSHolding(s) in Company
12th Dec 200711:35 amRNSHolding(s) in Company
28th Nov 20077:01 amRNSAcquisition
20th Nov 20076:39 pmRNSHolding(s) in Company
8th Nov 200710:37 amRNSHolding(s) in Company
8th Nov 20077:00 amRNSHolding(s) in Company
8th Nov 20077:00 amRNSHolding(s) in Company
8th Nov 20077:00 amRNSHolding(s) in Company
10th Oct 20078:00 amRNSFirst Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.